Curaleaf Launches US$83 Million Share Repurchase Program Approved by TSX

The latest update is out from Curaleaf Holdings ( (TSE:CURA) ).

On April 16, 2026, Curaleaf Holdings, Inc. announced that its board had authorized, and the Toronto Stock Exchange approved, a normal course issuer bid to repurchase up to 34,388,831 subordinate voting shares, about 5% of those outstanding as of April 10, 2026. The buyback, with an implied fair market value of roughly US$83 million based on the April 14 TSX closing price, will run from April 20, 2026 to no later than April 19, 2027 and all repurchased shares will be cancelled.

Management framed the move as a way to return capital to shareholders and signal confidence in the company’s strategy, noting that the stock may at times trade below its perceived intrinsic value. Conducted through the TSX and eligible Canadian alternative trading systems via designated broker ATB Cormark Capital Markets, the program gives Curaleaf flexibility on timing and volume within regulatory limits and marks its first normal course issuer bid in the past 12 months, potentially tightening its float and supporting earnings per share over time.

The most recent analyst rating on (TSE:CURA) stock is a Buy with a C$5.50 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page.

Spark’s Take on CURA Stock

According to Spark, TipRanks’ AI Analyst, CURA is a Neutral.

The score is held back primarily by persistent net losses, margin compression, and weak technical trends (negative MACD and trading below key moving averages). Offsetting factors include improving cash generation and management’s operational progress and de-risking actions discussed on the earnings call (notably cash flow strength and refinancing), but near-term revenue softness and continued pricing pressure limit upside.

To see Spark’s full report on CURA stock, click here.

More about Curaleaf Holdings

Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, serving both medical and adult-use markets under brands such as Curaleaf, Select, Grassroots, Find, Dark Heart and Anthem. Listed on the Toronto Stock Exchange and trading on the OTCQX, the company operates across Europe, Canada and Australasia with an integrated supply chain spanning cultivation, extraction, production and distribution.

Average Trading Volume: 549,981

Technical Sentiment Signal: Hold

Current Market Cap: C$2.79B

Learn more about CURA stock on TipRanks’ Stock Analysis page.